Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Generic Copaxone approval very unlikely this quarter, says Jefferies
Generic Copaxone approval very unlikely this quarter, says Jefferies
Generic Copaxone approval very unlikely this quarter, says Jefferies
Submitted by
admin
on May 28, 2014 - 9:24am
Source:
The Fly on the Wall
News Tags:
generics
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Headline:
Generic Copaxone approval very unlikely this quarter, says Jefferies
Do Not Allow Advertisers to Use My Personal information
